NEOG
Price
$5.46
Change
+$0.19 (+3.61%)
Updated
Sep 17 closing price
Capitalization
1.15B
12 days until earnings call
RVTY
Price
$85.39
Change
+$0.11 (+0.13%)
Updated
Sep 17 closing price
Capitalization
9.9B
47 days until earnings call
Interact to see
Advertisement

NEOG vs RVTY

Header iconNEOG vs RVTY Comparison
Open Charts NEOG vs RVTYBanner chart's image
Neogen
Price$5.46
Change+$0.19 (+3.61%)
Volume$11.38M
Capitalization1.15B
Revvity
Price$85.39
Change+$0.11 (+0.13%)
Volume$1.52M
Capitalization9.9B
NEOG vs RVTY Comparison Chart in %
Loading...
NEOG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEOG vs. RVTY commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEOG is a Hold and RVTY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (NEOG: $5.44 vs. RVTY: $85.39)
Brand notoriety: NEOG and RVTY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NEOG: 203% vs. RVTY: 114%
Market capitalization -- NEOG: $1.15B vs. RVTY: $9.9B
NEOG [@Medical Specialties] is valued at $1.15B. RVTY’s [@Medical Specialties] market capitalization is $9.9B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $10.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEOG’s FA Score shows that 1 FA rating(s) are green whileRVTY’s FA Score has 0 green FA rating(s).

  • NEOG’s FA Score: 1 green, 4 red.
  • RVTY’s FA Score: 0 green, 5 red.
According to our system of comparison, both NEOG and RVTY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEOG’s TA Score shows that 6 TA indicator(s) are bullish while RVTY’s TA Score has 4 bullish TA indicator(s).

  • NEOG’s TA Score: 6 bullish, 4 bearish.
  • RVTY’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, NEOG is a better buy in the short-term than RVTY.

Price Growth

NEOG (@Medical Specialties) experienced а -2.64% price change this week, while RVTY (@Medical Specialties) price change was +3.50% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.80%. For the same industry, the average monthly price growth was +2.74%, and the average quarterly price growth was +15.83%.

Reported Earning Dates

NEOG is expected to report earnings on Sep 30, 2025.

RVTY is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Medical Specialties (+1.80% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVTY($9.9B) has a higher market cap than NEOG($1.15B). NEOG has higher P/E ratio than RVTY: NEOG (865.00) vs RVTY (37.13). RVTY YTD gains are higher at: -23.334 vs. NEOG (-55.169). RVTY has higher annual earnings (EBITDA): 822M vs. NEOG (-935.82M). RVTY has more cash in the bank: 992M vs. NEOG (129M). NEOG has less debt than RVTY: NEOG (894M) vs RVTY (3.38B). RVTY has higher revenues than NEOG: RVTY (2.8B) vs NEOG (895M).
NEOGRVTYNEOG / RVTY
Capitalization1.15B9.9B12%
EBITDA-935.82M822M-114%
Gain YTD-55.169-23.334236%
P/E Ratio865.0037.132,330%
Revenue895M2.8B32%
Total Cash129M992M13%
Total Debt894M3.38B26%
FUNDAMENTALS RATINGS
NEOG vs RVTY: Fundamental Ratings
NEOG
RVTY
OUTLOOK RATING
1..100
8065
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9787
PRICE GROWTH RATING
1..100
6564
P/E GROWTH RATING
1..100
395
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RVTY's Valuation (47) in the Medical Specialties industry is somewhat better than the same rating for NEOG (96). This means that RVTY’s stock grew somewhat faster than NEOG’s over the last 12 months.

RVTY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NEOG (100). This means that RVTY’s stock grew similarly to NEOG’s over the last 12 months.

RVTY's SMR Rating (87) in the Medical Specialties industry is in the same range as NEOG (97). This means that RVTY’s stock grew similarly to NEOG’s over the last 12 months.

RVTY's Price Growth Rating (64) in the Medical Specialties industry is in the same range as NEOG (65). This means that RVTY’s stock grew similarly to NEOG’s over the last 12 months.

NEOG's P/E Growth Rating (3) in the Medical Specialties industry is significantly better than the same rating for RVTY (95). This means that NEOG’s stock grew significantly faster than RVTY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEOGRVTY
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
66%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
70%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
67%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 14 days ago
67%
Bullish Trend 1 day ago
68%
Declines
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 9 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
55%
Aroon
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
NEOG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTCVX38.79N/A
N/A
Fidelity Advisor Convertible Secs M
THIGX36.93N/A
N/A
Thornburg Small/Mid Cap Growth I
TRREX11.46N/A
N/A
T. Rowe Price Real Estate
RWGIX5.63N/A
N/A
Wedgewood Institutional
FZEMX47.36N/A
N/A
Fidelity Advisor Emerging Markets Z